Barrow, Hanley, Mewhinney & Strauss’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,444
Closed -$172K 329
2020
Q4
$172K Sell
1,444
-17
-1% -$2.07K ﹤0.01% 169
2020
Q3
$167K Hold
1,461
﹤0.01% 225
2020
Q2
$167K Sell
1,461
-413
-22% -$43.8K ﹤0.01% 295
2020
Q1
$150K Buy
1,874
+80
+4% +$8.28K ﹤0.01% 283
2019
Q4
$191K Hold
1,794
﹤0.01% 298
2019
Q3
$192K Buy
1,794
+393
+28% +$40.3K ﹤0.01% 301
2019
Q2
$142K Buy
1,401
+230
+20% +$22.1K ﹤0.01% 310
2019
Q1
$105K Buy
+1,171
New +$101K ﹤0.01% 322
2018
Q3
Sell
-1,450
Closed -$159K 409
2018
Q2
$159K Sell
1,450
-421
-23% -$43.9K ﹤0.01% 336
2018
Q1
$188K Buy
1,871
+1,105
+144% +$113K ﹤0.01% 335
2017
Q4
$75K Buy
766
+257
+50% +$24.4K ﹤0.01% 342
2017
Q3
$48K Sell
509
-252
-33% -$26.8K ﹤0.01% 363
2017
Q2
$85K Sell
761
-2
-0.3% -$211 ﹤0.01% 342
2017
Q1
$75K Buy
+763
New +$72.7K ﹤0.01% 345

Other funds holding DGX

Barrow, Hanley, Mewhinney & Strauss's DGX Position: Q1 2021 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 1,444 shares — an estimated $172K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in DGX in Q1 2017 and held it in 14 quarters. The position peaked at $192K in Q3 2019. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 1,444 Quest Diagnostics shares in Q1 2021, an estimated $172K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Quest Diagnostics in Q1 2017 and held it in 14 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Quest Diagnostics position peaked at $192K in Q3 2019.
  • 817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2021, filed 13 May 2021.